What's happening with the ResMed share price on Wednesday?

The ResMed share price is facing some quarterly headwinds today.

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price is edging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $29.30. In morning trade on Wednesday, shares are swapping hands for $29.34, up 0.1%.

For some context, the ASX 200 is up 0.6% at this same time.

Here's what's happening.

What's going on with the ASX 200 healthcare company?

The ResMed share price may be trailing the ASX 200 because the sleep treatment company's stock is trading ex-dividend today.

That means investors who buy the stock today will no longer be eligible for the 4.8 US cents per share unfranked dividend.

That passive income payout will go to investors who held ResMed shares at market close yesterday. Eligible investors can expect to see this hit their bank accounts on 14 March.

The company will report on the Aussie dollar equivalent for ASX investors on Friday, 9 February. (At time of writing AU$1 is worth 65.3 US cents.)

It's common for stocks to face some headwinds on the day they trade ex-dividend. All else being equal, the ResMed share price is now factored in at 4.8 US cents less than it would have been yesterday.

Unlike most ASX 200 stocks, ResMed pays dividends on a quarterly basis.

In the quarter just past, the company paid US$70.7 million in dividends. It also repurchased 335,000 shares for US$50 million as part of ResMed's ongoing capital management.

Overall, it was a strong quarter for the company, with revenue up 12% year on year (11% on a constant currency basis) to US$1.2 billion. And profits were well up, with non-GAAP operating profit leaping 20%.

Commenting on the outlook for the sleep treatment company on the day it reported, CEO Mick Farrell said, "ResMed is well-positioned to lean into leading the expansion and growth of sleep health and breathing health. We are the clear leader in a very large and growing market."

ResMed share price snapshot

The steep falls in August and September see the ResMed share price down 7% over 12 months.

Shares have soared 37% since the lows on 25 September.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Dividend Investing

2 of the best ASX dividend shares to buy according to Morgans

The broker is feeling very positive about these income options.

Read more »

A happy construction worker or miner holds a fistfull of Australian money, indicating a dividends windfall
Dividend Investing

Invest $10,000 in BHP shares and get $480 in passive income

Here's what sort of passive income Goldman Sachs expects from the Big Australian.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Energy Shares

What's driving New Hope shares' gigantic 8.4% dividend yield?

Is an 8.37% dividend yield too good to be true?

Read more »

A young woman holds onto her crown as another moves to take it, indicating rival ASX shares
Resources Shares

Can BHP stock regain its dividend crown?

Let’s dig into the passive income potential of this company.

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Dividend Investing

Buy Coles and these ASX dividend stocks

Brokers think these shares are in the buy zone right now. But why?

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Dividend Investing

An ASX dividend giant I'd buy over ANZ shares for 2024

ANZ would not be my first pick for passive income.

Read more »

Woman holding $50 and $20 notes.
Dividend Investing

Analysts think these high-yield ASX dividend shares are buy in May

Income investors might want to check out these top stocks.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Dividend Investing

4 excellent ASX dividend shares to buy in May

Analysts have put buy ratings on these stocks and are forecasting attractive dividend yields.

Read more »